Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries

MLA

Watson, Gabriella, et al. “Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-Income Countries.” The Pediatric Infectious Disease Journal, vol. 40, no. 12, Dec. 2021, pp. 1127–34. EBSCOhost, https://doi.org/10.1097/INF.0000000000003261.

APA

Watson, G., Dodd, C., Munoz, F. M., Eckert, L. O., Jones, C. E., Buttery, J. P., Yildirim, I. B., Kachikis, A., Heath, P. T., Schlaudecker, E. P., Bond, N. H., Santarcangelo, P. L., Wilcox, C. R., Bellamy, K., Elmontser, M., Sienas, L., Simon, R., Khalil, A., Townsend, R., … Black, S. (2021). Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries. The Pediatric Infectious Disease Journal, 40(12), 1127–1134. https://doi.org/10.1097/INF.0000000000003261

Chicago

Watson, Gabriella, Caitlin Dodd, Flor M. Munoz, Linda O. Eckert, Christine E. Jones, Jim P. Buttery, Inci B. Yildirim, et al. 2021. “Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-Income Countries.” The Pediatric Infectious Disease Journal 40 (12): 1127–34. doi:10.1097/INF.0000000000003261.